CRVS - Corvus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRVS is currently covered by 7 analysts with an average price target of $7.81. This is a potential upside of $4.31 (123.14%) from yesterday's end of day stock price of $3.5.

Corvus Pharmaceuticals's activity chart (see below) currently has 27 price targets and 35 ratings on display. The stock rating distribution of CRVS is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 60.71% with an average time for these price targets to be met of 311.88 days.

Highest price target for CRVS is $21, Lowest price target is $11, average price target is $12.13.

Most recent stock forecast was given by SEAN LEE from HC WAINWRIGHT on 26-Mar-2025. First documented stock forecast 05-Apr-2017.

Currently out of the existing stock ratings of CRVS, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$7.37 (203.03%)

$11

1 months 2 days ago
(26-Mar-2025)

0/3 (0%)

$7.65 (228.36%)

Buy

$13

$9.37 (258.13%)

$8

5 months 15 days ago
(13-Nov-2024)

1/2 (50%)

$4.13 (46.56%)

1059

Buy

$3.5

6 months 6 days ago
(22-Oct-2024)

1/1 (100%)

$1.71 (95.53%)

134

Buy

$21

$17.37 (478.51%)

$12

7 months 12 days ago
(16-Sep-2024)

1/4 (25%)

$15.22 (263.32%)

216

Buy

$4

1 years 27 days ago
(01-Apr-2024)

3/4 (75%)

$2.36 (143.90%)

376

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRVS (Corvus Pharmaceuticals) average time for price targets to be met?

On average it took 311.88 days on average for the stock forecasts to be realized with a an average price target met ratio 60.71

Which analyst has the current highest performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?

ROBERT DRISCOLL

Which analyst has the current lower performing score on CRVS (Corvus Pharmaceuticals) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on CRVS (Corvus Pharmaceuticals)?

Robert Driscoll works at WEDBUSH and has 17 price targets and 10 ratings on CRVS

Which analyst is the currently most bullish on CRVS (Corvus Pharmaceuticals)?

Aydin Huseynov with highest potential upside - $17.37

Which analyst is the currently most reserved on CRVS (Corvus Pharmaceuticals)?

Mara Goldstein with lowest potential downside - -$0.13

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?